Literature DB >> 18191861

Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells.

Ling-Hong Shen1, Lei Zhou, Bin-Yao Wang, Jun Pu, Liu-Hua Hu, Da-Jun Chai, Li Wang, Jin-Zhang Zeng, Ben He.   

Abstract

Dendtritic cells (DCs) are potent antigen-presenting cells and have an important role in the pathogenesis of atherosclerosis. Recent data suggests oxidized low-density lipoprotein (oxLDL) promotes the transition of a differentiating monocyte to a mature dendritic cell. In this study, we examined whether oxLDL could induce the differentiation of mature macrophages into DCs. After 48 h treatment with oxLDL, RAW264.7 cells increased in cell size and exhibited dendritic morphology. At the optimal oxLDL dose (10 microg/ml), approximately 74% of RAW264.7 cells differentiated into dendritic-like cells. Flow cytometric analysis detected dendritic cell surface markers (CD83, CD40, CD86, MHC Class II, and CD1d), and their expression increased in a dose- and time-dependent manner. Moreover, oxLDL-treated RAW264.7 cells showed functional changes including reduced endocytic activity, increased allostimulatory activity, and IL-12 production. The findings of the present work demonstrate that RAW264.7 cells, incubated with oxLDL, acquire some dendritic cell features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191861     DOI: 10.1016/j.atherosclerosis.2007.12.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

Review 1.  The role of heat shock proteins in atherosclerosis.

Authors:  Georg Wick; Bojana Jakic; Maja Buszko; Marius C Wick; Cecilia Grundtman
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

2.  Expression profiles of microRNAs in oxidized low-density lipoprotein-stimulated RAW 264.7 cells.

Authors:  Xiaokai Li; Siyuan Feng; Yi Luo; Keren Long; Zhenghao Lin; Jideng Ma; Anan Jiang; Long Jin; Qianzi Tang; Mingzhou Li; Xun Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-10       Impact factor: 2.416

3.  Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway.

Authors:  Liu-Hua Hu; Tuo Zhang; Qin Shao; Dan-Dan Li; Shu-Xuan Jin; Peng Nie; Jing Yi; Ben He; Ling-Hong Shen
Journal:  Mol Cell Biochem       Date:  2012-08-14       Impact factor: 3.396

4.  The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.

Authors:  Ming-xiu Hao; Li-sheng Jiang; Ning-yuan Fang; Jun Pu; Liu-hua Hu; Ling-Hong Shen; Wei Song; Ben He
Journal:  J Lipid Res       Date:  2010-03-20       Impact factor: 5.922

Review 5.  The autoimmune concept of atherosclerosis.

Authors:  Cecilia Grundtman; Georg Wick
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

6.  Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages.

Authors:  Lei Zhou; Ling-Hong Shen; Liu-Hua Hu; Heng Ge; Jun Pu; Da-Jun Chai; Qin Shao; Li Wang; Jin-Zhang Zeng; Ben He
Journal:  Mol Cell Biochem       Date:  2009-09-27       Impact factor: 3.396

7.  IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

Authors:  Rebecca A Sosa; Cathi Murphey; Rachel R Robinson; Thomas G Forsthuber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

Review 8.  Macrophage heterogeneity in atherosclerotic plaques.

Authors:  Jason L Johnson; Andrew C Newby
Journal:  Curr Opin Lipidol       Date:  2009-10       Impact factor: 4.776

9.  MicroRNA-155 induces differentiation of RAW264.7 cells into dendritic-like cells.

Authors:  Yu-Lan Ma; Zhi-Jun Ma; Min Wang; Meng-Yang Liao; Rui Yao; Yu-Hua Liao
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 10.  Dendritic cells in atherosclerotic disease.

Authors:  Alexander Niessner; Cornelia M Weyand
Journal:  Clin Immunol       Date:  2009-06-10       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.